课题基金 / 基金详情

Nucleoprotein Structures at Telomeres and Sites of DNA Damage

Nucleoprotein Structures at Telomeres and Sites of DNA Damage
端粒和 DNA 损伤位点的核蛋白结构
批准号:
8328567
负责人:
JACK D GRIFFITH
金额:
$31.46万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-26 至 2016-03-31

项目摘要

项目成果

JACK D GRIFFITH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):结构洞察力可以塑造新思维,并有助于范式转换的影响。端粒是癌症和衰老的核心。结构问题是端粒功能的核心,其中DNA修复途径的信号可能取决于端粒的物理变化。该实验室之前的工作导致了端粒环(t-环)和小端粒DNA环(t-环)的发现,它们现在已经从酵母到人类中被发现,可能有助于端粒的维持。另一个新的参与者是端粒RNA。hnRNPA1蛋白与这种RNA紧密结合,该实验室最近的研究表明,hnRNPA1将解开哺乳动物的双端粒DNA。这个研究项目应用了生物化学和透射电子显微镜(EM)的独特结合。新的EM标记方法已经开发出来,可以识别多蛋白复合物中的蛋白质,并将与新的超温和制备方法,低温EM和单颗粒重建方法一起应用,并结合生化分析。在AIM I中,高度纯化的核心端粒结合蛋白(TRF1, TRF2, Pot1, TPP1, hRap1和Tin2)与体内组装的这些蛋白的共复合物一起组装到模型端粒模板上,检查它们的结构,并确定它们重塑端粒DNA的能力。在AIM II中,使用转基因小鼠的实验将进一步探索TRF2的作用,并对Rad51类似物和WRN解旋酶进行研究,以研究这些修复因子与端粒DNA上的端粒复合物的相互作用。AIM III将重点关注端粒RNA和hnRNPA1在端粒上形成支架的能力,其他核心端粒结合因子可能在其上组装。hnRNPA1在促进端粒环化和复制延伸中的作用将被研究。Aim IV继续与Tomaska小组的长期合作,并发现了一种具有长端粒和端粒结合蛋白与人类TRF1/2高度同源的新型酵母物种。这种酵母应该为人类端粒生物学提供一个更好的模型。过去筹资期间的高生产力为未来的成功提供了强有力的衡量标准,而这得到了强有力的合作的支持。这些研究具有非常高的影响,因为没有其他实验室将这项技术应用于端粒/修复工作,而且许多其他实验室依赖于这些结构研究的输入。
英文摘要
DESCRIPTION (provided by applicant): Structural insights can shape new thinking and contribute paradigm-shifting impact. Telomeres are central to cancer and aging. Questions of structure are central to telomere function where signaling to the DNA repair pathway likely depends on physical changes in the telomere. Previous work from this laboratory led to the discovery of telomere looping (t-loops) and small telomeric DNA circles (t-circles) which have now been found from yeast to humans and likely contributes to telomere maintenance. A new player discovered by others is telomeric RNA bound at the telomere. hnRNPA1 protein binds this RNA tightly and recent work in this laboratory revealed that hnRNPA1 will unwind duplex mammalian telomeric DNA. This research program applies a unique combination of biochemistry and transmission electron microscopy (EM). New EM tagging methods that identify proteins in multiprotein complexes have been developed and will be applied along with new ultra-gentle preparative methods, cryoEM and single particle reconstruction methods, melded with biochemical assays. In AIM I, the core telomere binding proteins (TRF1, TRF2, Pot1, TPP1, hRap1, and Tin2) highly purified and in hand together with co-complexes of these proteins assembled in vivo will be assembled onto model telomere templates, their structure examined, and their ability to remodel telomeric DNA determined. In AIM II, experiments using transgenic mice will further probe role of TRF2, and work on the Rad51 paralogs and the WRN helicase will be conducted to examine the interaction of these repair factors with the telomere complexes on telomeric DNA. AIM III will focus on telomeric RNA and hnRNPA1 in their ability to form a scaffold at the telomere upon which other core telomere binding factors may assemble. The role of hnRNPA1 in facilitating looping and replicative extension of the telomere will be investigated. Aim IV continues a long standing collaboration with the Tomaska group and the discovery of a novel new yeast species with long telomeres and telomere binding protein highly homologous to human TRF1/2. This yeast should provide a better model for human telomere biology. The high productivity of the past funding period provides a strong metric for future success and this is bolstered by strong collaborations. These studies have very high impact since no other laboratory is applying this technology to telomere/repair work and many other laboratories depend on the input from these structural studies. .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
R-loops at the telomere as a toxic source of genomic instability
R-loops at the telomere as a toxic source of genomic instability
R-loops at the telomere as a toxic source of genomic instability
Instrumentation for upgrading cryoEM and single particle analysis capabilities
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: